Bristol Myers Squibb Stock Price on November 1, 2022
BMY Stock | USD 44.85 0.15 0.34% |
Below is the normalized historical share price chart for Bristol Myers Squibb extending back to June 01, 1972. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bristol Myers stands at 44.85, as last reported on the 27th of April, with the highest price reaching 45.37 and the lowest price hitting 44.34 during the day.
If you're considering investing in Bristol Stock, it is important to understand the factors that can impact its price. Bristol Myers Squibb secures Sharpe Ratio (or Efficiency) of -0.0829, which signifies that the company had a -0.0829% return per unit of risk over the last 3 months. Bristol Myers Squibb exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bristol Myers' Standard Deviation of 1.61, risk adjusted performance of (0.05), and Mean Deviation of 1.05 to double-check the risk estimate we provide.
At this time, Bristol Myers' Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 2 B in 2024, whereas Total Stockholder Equity is likely to drop slightly above 15 B in 2024. . At this time, Bristol Myers' Price To Sales Ratio is fairly stable compared to the past year. Price Earnings Ratio is likely to rise to 19.89 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop 7.28 in 2024. Bristol Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of January 1972 | 200 Day MA 54.3517 | 50 Day MA 51.1098 | Beta 0.39 |
Bristol |
Sharpe Ratio = -0.0829
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BMY |
Estimated Market Risk
1.65 actual daily | 14 86% of assets are more volatile |
Expected Return
-0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bristol Myers is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bristol Myers by adding Bristol Myers to a well-diversified portfolio.
Price Book 3.3249 | Enterprise Value Ebitda 6.5597 | Price Sales 2.1742 | Shares Float 2 B | Dividend Share 2.31 |
Bristol Myers Main Headline on 1st of November 2022
Bristol Myers Squibb dividend paid on 1st of November 2022 |
Bristol Myers Valuation on November 1, 2022
It is possible to determine the worth of Bristol Myers on a given historical date. On November 1, 2022 Bristol was worth 77.0 at the beginning of the trading date compared to the closed value of 73.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bristol Myers stock. Still, in general, we apply an absolute valuation method to find Bristol Myers' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bristol Myers where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bristol Myers' related companies.
Open | High | Low | Close | Volume | |
76.59 | 78.66 | 73.10 | 73.10 | 12,380,800 | |
11/01/2022 | 77.00 | 77.79 | 73.31 | 73.31 | 8,870,700 |
77.66 | 78.91 | 73.08 | 73.08 | 8,570,700 |
Backtest Bristol Myers | | | Bristol Myers History | | | Bristol Myers Valuation | Previous | Next |
Bristol Myers Trading Date Momentum on November 1, 2022
On November 02 2022 Bristol Myers Squibb was traded for 73.08 at the closing time. Highest Bristol Myers's price during the trading hours was 78.91 and the lowest price during the day was 73.08 . The net volume was 8.6 M. The overall trading history on the 2nd of November contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 0.31% . The overall trading delta to current price is 6.53% . |
Bristol Myers Squibb Fundamentals Correlations and Trends
By evaluating Bristol Myers' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bristol financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bristol Myers Stock history
Bristol Myers investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bristol is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bristol Myers Squibb will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bristol Myers stock prices may prove useful in developing a viable investing in Bristol Myers
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2.1 B | 1.6 B | |
Net Income Applicable To Common Shares | 5.7 B | 6 B |
Bristol Myers Quarterly Net Working Capital |
|
Bristol Myers Stock Technical Analysis
Bristol Myers technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bristol Myers Period Price Range
Low | November 1, 2022
| High |
77.00 | 73.31 |
Bristol Myers April 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Bristol Myers stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bristol Myers shares will generate the highest return on investment. By undertsting and applying Bristol Myers stock market strength indicators, traders can identify Bristol Myers Squibb entry and exit signals to maximize returns
Accumulation Distribution | 510872.0 | |||
Daily Balance Of Power | (0.82) | |||
Rate Of Daily Change | 0.95 | |||
Day Median Price | 75.55 | |||
Day Typical Price | 74.8 | |||
Price Action Indicator | (4.09) | |||
Period Momentum Indicator | (28.46) |
Bristol Myers Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bristol Myers' price direction in advance. Along with the technical and fundamental analysis of Bristol Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bristol to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.19) | |||
Total Risk Alpha | (0.36) | |||
Treynor Ratio | (0.29) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.09) | Dividend Share 2.31 | Earnings Share 3.86 | Revenue Per Share 21.753 | Quarterly Revenue Growth 0.006 |
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.